top of page
MyHep LVIR Tablet

MyHep LVIR Tablet – Ledipasvir 90mg + Sofosbuvir 400mg Hepatitis C Treatment

MyHep LVIR (Ledipasvir / Sofosbuvir) (generic equivalent to Harvoni) is a prescription direct-acting antiviral (DAA) used to treat Chronic Hepatitis C Virus (HCV) infection. Modern DAA therapies like MyHep LVIR deliver cure rates exceeding 95% in most HCV genotypes.
Composition: Ledipasvir (90mg) + Sofosbuvir (400mg)
Treatment Course: Typically 8–12 weeks.
Manufacturer: Mylan Pharmaceuticals Pvt Ltd
Prescription-only antiviral. Use under the supervision of a hepatologist or infectious disease specialist. Baseline genotyping and viral load testing required before starting treatment.
  • Composition

    Ledipasvir (90mg) + Sofosbuvir (400mg)
    Dosage Form

    Tablets
    Equivalent brand

    Ledipasvir and Sofosbuvir
    Generic Name

    Ledipasvir/ Sofosbuvir
    Indication

    Hepatitis C
    Manufacturer

    Mylan Pharmaceuticals Pvt Ltd
    Packaging

    28 tablets in 1 bottle
$480.00Price
Quantity
bottom of page